<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04371055</url>
  </required_header>
  <id_info>
    <org_study_id>Find-AF 2</org_study_id>
    <nct_id>NCT04371055</nct_id>
  </id_info>
  <brief_title>Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study</brief_title>
  <acronym>Find-AF2</acronym>
  <official_title>Intensive Heart Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who have suffered a stroke are having an increased risk of having recurrent stroke&#xD;
      in the future. This risk of stroke is increased by atrial fibrillation, which often &quot;comes&#xD;
      and goes&quot; (called paroxysmal) and hence escapes routine diagnostics. The hypothesis of&#xD;
      Find-AF 2 is that enhanced (evaluation in a ECG core lab), prolonged (at least 7 days of&#xD;
      rhythm monitoring annually) and intensified (continuous rhythm monitoring in high risk&#xD;
      patients) not only finds atrial fibrillation more often, but that changes in therapeutic&#xD;
      management (e. g. start of anticoagulation after detection of atrial fibrillation) results in&#xD;
      a decrease of cardioembolism (which can be either recurrent stroke or systemic embolism).&#xD;
&#xD;
      To prove this hypothesis, patients will be randomised into two groups: the first group will&#xD;
      receive the currently available standard care for patients with stroke. In the second group,&#xD;
      cardiac rhythm monitoring adapted to the risk of the occurrence of atrial fibrillation is&#xD;
      performed - either with a 7-day long-term ECG (at baseline, after 3 and 12 months and every&#xD;
      12 months thereafter) or with continuous monitoring using an implantable cardiac monitor. If&#xD;
      atrial fibrillation is detected, this information will be given to the treating study&#xD;
      physician. Any therapeutic decision is at the discretion of the treating physician, but&#xD;
      should follow current guidelines.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Find AF 2 study will investigate whether intensified rhythm monitoring in patients with&#xD;
      recent ischemic stroke leads to a decrease in recurrent thromboembolism (defined as recurrent&#xD;
      ischemic stroke or systemic embolism). This will be achieved by identifying patients with&#xD;
      paroxysmal atrial fibrillation and subsequently switching secondary prevention therapy from&#xD;
      antiplatelet therapy to oral anticoagulation. The intensity of heart rhythm monitoring will&#xD;
      be risk-adjusted: Patients with an estimated low risk of atrial fibrillation receive a 7-day&#xD;
      Holter ECG, which is repeated after 3 and 12 months and annually thereafter. Patients with a&#xD;
      high risk of atrial fibrillation (defined by increased supraventricular ectopic activity)&#xD;
      receive continuous ECG monitoring using an implanted loop recorder. The control arm is&#xD;
      treated according to local standards, which includes cardiac rhythm monitoring for at least&#xD;
      24 hours according to current guidelines. Prior to randomization, a 24-hour Holter ECG is&#xD;
      performed in both study arms, ensuring minimal ECG monitoring for patients in the control arm&#xD;
      and allowing risk stratification in the intervention arm. Additional ECG monitoring using&#xD;
      stroke telemetry and/or additional Holter ECGs is possible according to local standards,&#xD;
      provided it does not exceed 7 days. Patients in both study arms will be followed up for at&#xD;
      least 24 months.&#xD;
&#xD;
      It should be noted that this study only provides diagnostic information, the therapeutic&#xD;
      decision is left to the treating physician.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 7, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised, parallel, multicenter interventional trial with blinded assessment of the primary endpoint</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary efficacy endpoint: Time until recurrent ischemic stroke or systemic embolism</measure>
    <time_frame>from the date of randomization until the date of first documented ischemic stroke or date of first systemic embolism, whichever comes first, assessed up to 60 months</time_frame>
    <description>The trial will be event driven. The minimum follow-up in each patient is 24 months, but may be followed for up to 60 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary safety endpoint: Time until the first haemorrhagic stroke</measure>
    <time_frame>from the date of randomization until the date of first documented haemorrhagic stroke, assessed up to 60 months</time_frame>
    <description>Time until the first haemorrhagic stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time until the combination of stroke, myocardial infarction and cardiovascular death</measure>
    <time_frame>from the date of randomization until the date of first documented stroke, the date of myocardial infarction and the date of cardiovascular death, whichever comes first, assessed up to 60 months</time_frame>
    <description>Time until the combination of stroke, myocardial infarction and cardiovascular death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until any stroke</measure>
    <time_frame>from the date of randomization until the date of first documented any stroke, assessed up to 60 months</time_frame>
    <description>Time until any stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until new onset of AF</measure>
    <time_frame>from the date of randomization until the date of first documented AF, assessed up to 60 months</time_frame>
    <description>Time until new onset of Atrial Fibrillation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until all cause mortality</measure>
    <time_frame>from the date of randomization until the date of all cause mortality assessed up to 60 months</time_frame>
    <description>Time until all cause mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until myocardial infarction</measure>
    <time_frame>from the date of randomization until the date of all myocardial infarction, assessed up to 60 months</time_frame>
    <description>Time until myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life (QoL), measured by the stroke impact scale (SIS-16)</measure>
    <time_frame>Mean change from baseline until study end assessed up to 60 months in both study arms</time_frame>
    <description>Changes in quality of life (QoL), measured by the stroke impact scale (SIS-16). The SIS-16 ranges from 16 to 80, with higher scores showing better Quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the EQ-5D five dimensional Quality of Life (QoL)</measure>
    <time_frame>Mean change from baseline until study end assessed up to 60 months in both study arms</time_frame>
    <description>Changes in the EQ-5D five dimensional Quality of Life (QoL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the overall QoL visual analog scale</measure>
    <time_frame>Mean change from baseline until study end assessed up to 60 months in both study arms, ranging from 0 to 100, with higher values indicating better quality of life</time_frame>
    <description>Changes in the overall QoL visual analog scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5200</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Risk-adapted ECG monitoring for atrial fibrillation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Group with high Risk for AF:&#xD;
Continuous Rhythm Monitoring using an implantable cardiac Monitor&#xD;
Intervention group with low risk for AF:&#xD;
7-day Holter ECG at baseline, after 3 and 12 months and then annually until the end of the study or the first occurrence of atrial Fibrillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care rhythm monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>7-day Holter ECG</intervention_name>
    <description>7-day Holter ECG at baseline and after 3 and 12 months and then annually until the end of the study or the first (in patients with low risk of atrial fibrillation)</description>
    <arm_group_label>Risk-adapted ECG monitoring for atrial fibrillation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implantable cardiac monitor</intervention_name>
    <description>Continuous rhythm monitoring using an implantable cardiac monitor</description>
    <arm_group_label>Risk-adapted ECG monitoring for atrial fibrillation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Usual care according to current guidelines (in patients with low and high risk of atrial fibrillation)</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Recent ischemic stroke (sudden focal neurologic deficit lasting &gt; 24h consistent with&#xD;
             the territory of a major cerebral artery) and/or a corresponding lesion on brain&#xD;
             imaging within the last 30 days&#xD;
&#xD;
          2. Age ≥ 60 years&#xD;
&#xD;
          3. Patient without or with only slight disability (modified Rankin Scale score ≤ 2)&#xD;
             before onset of stroke-related symptoms.&#xD;
&#xD;
          4. Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known history of atrial fibrillation/flutter or atrial fibrillation/flutter on&#xD;
             admission ECG&#xD;
&#xD;
          2. Current indication or contraindication for oral anticoagulation at randomisation&#xD;
&#xD;
          3. Intracerebral bleeding in medical history&#xD;
&#xD;
          4. Patient scheduled for ECG-monitoring lasting &gt; 7 days (Holter-ECG, implanted loop&#xD;
             recorder, etc.)&#xD;
&#xD;
          5. Implanted pacemaker device or cardioverter/ defibrillator&#xD;
&#xD;
          6. Patient not willing to be treated with oral anticoagulants&#xD;
&#xD;
          7. Carotid artery stenosis ipsilateral to the current ischemic stroke needing operation&#xD;
             or intervention.&#xD;
&#xD;
          8. History of carotid endarterectomy or percutaneous intervention of cerebral artery&#xD;
             within the last 30 days.&#xD;
&#xD;
          9. Life expectancy &lt;1 year for reasons other than stroke (e.g. metastatic cancer)&#xD;
&#xD;
         10. patients under legal supervision or guardianship&#xD;
&#xD;
         11. psychological/mental or other inabilities to supply required information (e.g. fill&#xD;
             out the questionnaire due to dementia, language difficulties,...) or participate in&#xD;
             the required tests&#xD;
&#xD;
         12. participation in other randomised interventional trials&#xD;
&#xD;
         13. suspected lack of compliance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rolf Wachter, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Leipzig, Clinic and Policlinis for Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Klaus Gröschel, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Mainz, Clinic and Policlinis for Neurology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rolf Wachter, Prof. Dr.</last_name>
    <phone>+49-341-97-12650</phone>
    <email>rolf.wachter@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katrin Wasser, PD Dr. med.</last_name>
    <phone>+49-551-3920-194</phone>
    <email>k.wasser@med.uni-goettingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ISD München</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Dichgans, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Leipzig, Clinic for Neurology</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominik Michalski, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Rolf Wachter, Prof. Dr.</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Klinikum Altenburger Land</name>
      <address>
        <city>Altenburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Berrouschot, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Aschaffenburg-Alzenau</name>
      <address>
        <city>Aschaffenburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oliver Bähr, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Ertl, PD Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rhön Klinikum Campus Bad Neustadt</name>
      <address>
        <city>Bad Neustadt An Der Saale</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hassan Soda, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sozialstiftung Bamberg; Klinikum am Bruderwald</name>
      <address>
        <city>Bamberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herwig Strik, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Spandau</name>
      <address>
        <city>Berlin-Spandau</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Müller, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BG Klinikum, Unfall-KH Berlin gGmbH</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirko Seidel, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Neukölln Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darius G Nabavi, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vivantes, Humboldt-Klinikum Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bettina Schmitz, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Klinikum Bethel, Klinik für Neurologie</name>
      <address>
        <city>Bielefeld</city>
        <zip>33611</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolf R Schäbitz, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Petzold, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen Mitte</name>
      <address>
        <city>Bremen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Kastrup, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg, Medizinische Klinik für Innere Medizin und Kardiologie</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Mahnkopf, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Kollmar, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Dresden, Standort Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Schellong, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars P Pallesen, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernd Kallmünzer, PD Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Essen, Clinic for Neurology</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Köhrmann, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Frankfurt Höchst</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Steiner, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Kurka, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Fulda</name>
      <address>
        <city>Fulda</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Neumann-Haefelin, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg GmbH</name>
      <address>
        <city>Gießen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Jünemann, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Hagen Huttner, Prof. Dr.</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Göttingen, Clinic for Neurology</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Liman, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bezirkskrankenhaus Günzburg</name>
      <address>
        <city>Günzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard F Hamann, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Martha-Maria Halle-Dölau</name>
      <address>
        <city>Halle</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Hoffmann, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albertinenkrankenhaus Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Rosenkranz, PD Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Altona Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Röther, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Wandsbek, Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Marquardt, PD Dr. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Götz Thomalla, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Weißenborn, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter A. Ringleb, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Höxter</name>
      <address>
        <city>Höxter</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Obermann, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Ibbenbüren</name>
      <address>
        <city>Ibbenbüren</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Bethke, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westpfalz Klinikum GmbH - Standort Kaiserslautern</name>
      <address>
        <city>Kaiserslautern</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ernst T Hammen, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum St. Georg Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Zinke, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Lüneburg gemeinnützige GmbH</name>
      <address>
        <city>Lüneburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Waltraud Pfeilschifter, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Mainz, Clinic for Neurology</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Gröschel, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Carl-von-Basedow Klinikum Merseburg</name>
      <address>
        <city>Merseburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carsten Hobohm, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Minden</name>
      <address>
        <city>Minden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Schellinger, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ökumenisches Hainich Klinikum Mühlhausen</name>
      <address>
        <city>Mühlhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Jauß, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jens Minnerup, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Osnabrück GmbH</name>
      <address>
        <city>Osnabrück</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars U Krause, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Passau</name>
      <address>
        <city>Passau</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Freilinger, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nordwest-Krankenhaus Sanderbusch, Klinik für Neurologie</name>
      <address>
        <city>Sande</city>
        <zip>26452</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pawel Kermer, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kreisklinikum Siegen</name>
      <address>
        <city>Siegen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Grond, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Südostbayern AG, Klinikum Traunstein</name>
      <address>
        <city>Traunstein</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorleif Etgen, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven Poli, PD Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katharina Althaus, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Dr. Horst Schmidt-Kliniken Wiesbaden</name>
      <address>
        <city>Wiesbaden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frank A Wollenweber, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl G Häusler, Prof. Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.find-af2.com</url>
    <description>Study homepage with information for medical experts and the general public</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2020</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Rolf Wachter</investigator_full_name>
    <investigator_title>Professor for Clinical and Interventional Cardiology</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Ischemic Stroke</keyword>
  <keyword>ECG Monitoring</keyword>
  <keyword>Secondary Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>after publication of the major results</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

